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Background: Only limited data are available on the outcome of tension-free obturator tape (TOT) procedures in
overweight and obese women. We would like to verify the objective and subjective outcomes of TOT in women
with a higher body mass index (BMI).
Methods: We evaluated the records of 116 patients who had undergone TOT, stratifying by BMI into normal
weight (n = 31), overweight (n = 56), and obese (n = 29) groups. We compared pre- and postoperative evaluations,
including subjective and objective outcome of TOT, complications, and quality of life assessed by validated
questionnaires (ICIQ-SF and KHQ).
Results: The median follow-up was 21 months. There were no significant differences between different groups in
terms of objective cure rate and subjective success, quality of life scores and postoperative complications.
Conclusions: Our data demonstrate that TOT procedure is safe and effective. BMI did not influence the outcome of
TOT procedures at a median of 21 months after surgery and represents no contraindication for continence surgery.
The success of the outcome of TOT procedure in females and the occurrence of complications are not negatively
affected by obesity.
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Stress urinary incontinence (SUI) is the complaint of invol-
untary loss of urine on effort or physical exertion (e.g. sport-
ing activities), or on sneezing or coughing [1]. Usually it is
caused by weak or damaged muscles and connective tissues
in the pelvic floor, compromising urethral support, or by
weakness of the urethral sphincter itself [2,3]. Among the
main risk factors are age, pregnancy, childbirth, obesity and
poor collagen turnover [4]. Typically, the first-line treatment
is conservative, which includes pelvic floor training, elec-
trical stimulation and biofeedback. In addition, Duloxetine
has been licensed for treatment of SUI in women and has
been shown to improve quality of life [5] but it is unclear
whether the benefit is lasting [6]. If the condition does not
improve, surgical alternatives can be offered. These include
retropubic colposuspension, slings and urethral bulking in-
jections [7]. Of these types of operations, the midurethral* Correspondence: frohme@med.uni-marburg.de
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reproduction in any medium, provided the orsling is currently the most common procedure performed
either alone or along with concomitant pelvic floor or ab-
dominal surgery. Transobturator tape (TOT) is similar to
the initial tension free vaginal tape (TVT), but a different
technique is used to insert the tape [8] However, TVT and
TOT showed no significant difference concerning to the
cure rate. The procedures may be comparable in terms of
patient satisfaction after more than 24 month of follow-up
[9,10]. The transobturator technique has the potential to re-
duce the incidence of significant complications associated
with the retropubic approach. This technique has been fur-
ther refined by the availability of the Monarc Subfascial
Hammock (American Medical Systems, Inc., Minnetonka,
MN, USA). Also obesity represents a risk factor for SUI [11]
today there are only limited data available concerning safety,
efficacy and outcome of TOT sling procedure in obese fe-
males. The aim of our study was to evaluate the clinical out-
come after TOT procedure with special interest concerning
different weight levels of women. A comparison of efficacy
and safety of TOT between overweight and normal weight
patients was performed.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Patient data
All consecutive women who underwent a TOT proced-
ure at the University hospital Marburg, Department of
Urology and Pediatric Urology, between January 2004
and January 2011 were retrospectively assessed (patients
history, level of SUI, age, body weight etc.). They all had
undergone conservative therapy options over minimal
three months including urotherapy (meaning behav-
ioural training) and pelvic floor workout. All patients
signed an informed consent for the collection and ana-
lysis of their data.
The patients were classified into 3 groups according to
the WHO body mass index (BMI): Group A (normal
BMI <25kg/m2), Group B (overweight BMI 25-30kg/m2),
Group C (obese BMI > 30kg/m2).
Preoperative diagnostics
All patients were urodynamically diagnosed with SUI. If
mixed symptoms were present, like urgency, frequency
or nocturia, the stress urinary incontinence predomi-
nated on review of the patient’s history. Patients with
mixed or isolated urge incontinence were excluded.
Multichannel urodynamic testing included post void re-
sidual urine (PVR) determination, multichannel cysto-
metrogram (CMG), and uroflowmetry. Patients were
excluded if PVR exceeded 100 ml or CMG had detrusor
overactivity. Mixed incontinence was defined by the
presence of sensory urge incontinence or detrusor over-
activity as well as stress incontinence during urodynamic
examination.
Surgical technique
TOT was performed using the “Monarc Subfascial
Hammock” (American Medical Systems, USA). The Monarc®
system includes a specially designed helical needle,
which uses a transobturator-to-vagina (outside-in tech-
nique) approach for mesh placement. The procedures
were performed with the patient in high lithotomy pos-
ition and under spinal or general anesthesia, according
to patient’s preference. All received single-shot broad-
spectrum intravenous antibiotics. Patients were instructed
to avoid heavy lifting, exercise, and sexual intercourse for
a minimum of 4 weeks postoperatively.
Postoperative evaluation
Intraoperative events including blood loss, time for
Monarc® implantation, any complications, and additional
procedures were recorded. Subjects were seen at rou-
tinely scheduled 12 and 52 weeks postoperatively. Some
patients took also different dates for personal reasons.
Information regarding continence status was obtained
and recorded. Standardized incontinence and quality of
life questionnaires as the ICI Questionnaire Short Form(ICIQ-SF) and the King’s Health questionnaire (KHQ)
were used. Repeat urodynamics were not utilized. Cure
was defined as no leakage (dry), or minimal leakage not
requiring protection (substantially dry), reported by the
patient, along with no leakage seen during an in office
stress test. Also improvement was defined as a reduction
in the use of pads of about 50% or more. Outcome mea-
sures reported include continence status, pad use, urin-
ary urgency, need for medication for urgency, urinary
retention (PVR >100 ml), and any healing difficulties. All
terminology was in accordance with current ICS termin-
ology, except where noted differently [12].
Statistics
Patient demographics, clinical history, preoperative, surgi-
cal, and postoperative data were summarized using de-
scriptive statistics for continuous variables and frequency




A total of 116 sequential female patients with symptom-
atic SUI underwent a TOT procedure at the University
hospital Marburg, Deptartment of Urology and Pediatric
Urology between January 2004 and January 2011. Mean
age was 62.5 years (range 36–83).
Concomitant surgery with anterior or/and posterior col-
porrhaphy were preformed during TOT procedure in 19
women (anterior = 16, posterior =1, both = 2). Additionally
in 1 patient a simultaneous resection of a urethral polyp
was performed.
The range of BMI in the patients was 18–47 kg/m2
with a median BMI of 27.5 kg/m2. The patients were
followed up between 2 and 56 months with a median
follow up of 21 months.
BMI-Groups
Dividing the women concerning their body weight there
were 31 women in Group A (normal BMI <25kg/m2), 56
women in Group B (overweight BMI 25-30kg/m2) and
29 women in Group C (obese BMI >30kg/m2) with a
mean age of 62 years (37–80) in Group A, 63 years (36–
83) in Group B and 60 years (38–78) in Group C. The
median BMI was 23,4 kg/m2 (18–24.8) in Group A, 28,1
kg/m2 (25,1-30) in Group B and 35,4 kg/m2 (30.1-47.2)
in Group C. 25% of the patients in Group A underwent
a co-therapy, 20% in Group B but only 7% in Group C.
Operation time
Overall operation time including the cases with con-
comitant surgery was 40 min (10–120). No significant
differences were detectable between the groups: 38.5
Figure 1 Pad consumption before and after surgery broken down by groups.
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and 36 min (15–120) in Group C.
Success of procedure
After TOT-procedure the used median pads/day signifi-
cantly reduced from baseline 4 (1–16) to 0 (0–9) (p < 0.01),
without showing some significant differences between the
BMI-groups. We found a significant improvement after
surgery without significant differences between the groups
(Figure 1).
Used pads/day after 6, 12, 24 and 36 months showed a
significant reduction compared to baseline in every
group without significant differences between the re-
spective BMI-groups. Comparing possible impairment
during time period (6, 12, 24, 36 months) no significant
increase of pads/day were evident in every group and be-
tween Group A, Group B and Group C (Table 1).
Success rate was 93% with a cure rate of 83% and im-
provement in 10% of the women. No significant differ-
ences were evident between the groups (Group A: 96%,
Group B: 94%, Group C: 91%).
Logistic analysis also revealed that BMI, history of pre-
vious pelvic surgery, concomitantly performed pelvic
surgery, or occurrence of complications did not affect
cure rates.Table 1 Median used pads/day 6, 12, 24 and 36 months
after TOT-procedure in group A, B and C (n = number of
patients, range of used pads)
6 months 12 months 24 months 36 months
Group A 1 (n = 30,
0-4)
1 (n = 28, 0-4) 1 (n = 18, 0-4) 0 (n = 11,
0-1)
Group B 0 (n = 52,
0-9)
0 (n = 35, 0-6) 1 (n = 23, 0-6) 0 (n = 10,
0-3)
Group C 0 (n = 25,
0-7)
0.5 (n = 21, 0-7) 0.5 (n = 16, 0-2) 0 (n = 10,
0-1)Complications
Overall complication rate was 23.2% (27/116) including
1 major (bleeding) and 26 minor complications (see
Table 2). Postoperative temporary voiding difficulty was
the main postoperative complication (n = 21, 18.1%). We
found appearance of de-novo-urge in 15 women (12.9%)
and temporary obstructive voiding in 6 women (5.2%)
with a urinary retention in 2 women (1.7%). Mean re-
sidual urine volume increased to 75 ml, only 3 patients
showed an increase above 100 ml (up to 330 ml). Void-
ing was not impaired by reduction of the flow time.
There was no significant change after performing the
operation while the range about the flow was 5–57 sec.
Also the maximum flow was not significantly affected.
Complication rates between the BMI-groups were
nearly similar without significant differences.Patients satisfaction
KHQ showed significant improvement in Quality of Life
in all circumstances for all different groups. No significant
differences between the groups were notable. Majority of
women (93%) are satisfied with the TOT-procedure in-
cluding individual outcome and recommend the proced-
ure, also without significant differences between the
groups (Group A: 100%, Group B: 90%, Group C: 89.5%).
We used the question “Would you repeat this procedure?”Table 2 Postoperative complication rate was 23.2%










Group A 1 4 1 3 1
Group B Ø 7 3 2 Ø
Group C Ø 4 Ø 1 Ø
Figure 2 KHQ showed significant improvement in QoL without differences between the three groups.
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measurement in the postoperative evaluation (Figure 2).
All relevant data, divided into different BMI-groups
were summarized in Table 3.
Discussion
This study showed that TOT was equally safe and effect-
ive for treating SUI regardless of BMI. The postoperative
quality of life was similarly improved for women in each
weight groups, and there were no significant differences
in the complication rate.
BMI is significantly correlated with intra-abdominal
pressure [13] which may increase stress on the pelvic
floor, contributing to the development and recurrence of
SUI. However, we did not find that women with a higher
BMI were more likely to have SUI on follow-up. Results
of the studies of incontinence surgery in obese patients
have been contradictory. Responses to a mailed ques-
tionnaire by 970 women who underwent TVT indicated
a markedly unfavorable outcome in 61 very obese
women (BMI > 35 kg/m2) [14]. The overall cure rate in
291 women of normal weight was 81.2%, as compared to
52.1% in the 61 very obese. In other studies these data
could not be confirmed and reasons for this poor out-
come are not clear. Maybe it is due to the limitations of
a mailed questionnaire reflecting the general enhanced





Group A (-25 kg/m2) 31 62.2 (37-80) 23.4 (18-24.8)
Group B (25-30kg/m2) 56 63 (36-83) 28.1 (25.1-30)
Group C (>30kg/m2) 29 60.3 (38-78) 35.4 (30.1-47.2)
Σ 116 62 (36-83) 27.5 (18-47.2)evaluated 195 women who underwent TVT. At one year
of follow-up, they found a similar surgical outcome
among 68 normal-weighted, 65 overweight and 62 obese
women [16]. The proportion of subjects with SUI one
year after surgery was 18% in the obese, 14% in the over-
weight, and 19% in the normal weight groups, differ-
ences were statistically not significant. Skriapas et al.
compared 31 morbidly obese patients with BMI > 40 kg/m2
and 52 patients with a BMI of <30 kg/m2 with a mean
follow-up of 18.5 months. The objective cure rate in con-
trol group was 92.3% and 86.9% for morbidly obese group,
so no significant difference was shown. They thus sug-
gested that TVT is a good option for morbidly obese pa-
tients with severe stress incontinence [17]. Differences
between the studies are caused by different lengths of
follow-up, variation in the type of continence surgery, and
different definitions of cure. Therefore comparability be-
tween this studies is limited (may not always be given). Also
in two studies using the transobturator tape procedures no
significant association between BMI and surgical outcome
were found [18,19]. Even if cure was defined differently in
these two studies the results are in line with our findings
after a follow up of nearly 2 years. In the publication of Po-
En Liu and coworkers the gain was the use of objective as
well as subjective measures of cure. Compared with the
normal weight group, women with a higher BMI did ap-








38.5 (18-85) 10 96% 4.5 (1-11) 0.85 (0-4)
43.6 (10-120) 12 94% 4.7 (1-16) 1.1 (0-9)
36 (15-120) 5 91% 5 (3-7) 1.4 (0-6)
40 (10-120) 27 (25.5%) 93% 4 (1-16) 0 (0-9)
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ing phase of urodynamic studies. The statistical analysis did
not indicate any significant differences among the groups,
although it is possible that some difference might be found
if the number of cases were higher. Instead of the ICIQ-SF
and KHQ they used UDI-6 and IIQ-7 scores. However,
they also find a significant improvement in all compared
groups so that the TOT procedure indeed improves quality
of life regardless of BMI.
Liapis et al. reported an objective cure in 82.4% of 115
subjects after TOT based on the pad test finding at 4
years postoperatively [20], while there was a slightly
lower objective success rate at a median of 24 months of
follow-up. Albo et al. described similar objective success
rates comparing TVT (77.3%) and TOT (72.3%) after 24
month follow-up in 516 women [10]. In our population
success rate of 93% after 21 month of follow up was
similar with cure rate of 83% and improvement of 10%.
In 2012 also a one-year outcome of mid-urethral sling
procedures for stress urinary incontinence according to
body mass index was published. The retrospective clin-
ical trial was performed with 284 patients treated by the
SPARC sling procedure and 49 patients also treated by
the MONARC sling procedure. The women were also
classified into 3 groups by BMI according to the WHO
Expert Consultation. Patient’s characteristics and clinical
outcomes of the operation were analyzed according to
BMI at 1 year after surgery but only via questionnaires
and interviews. The objective and subjective cure rates
for the obese group were worse after TOT procedure
(96.8% vs. 66.7%) but because of the small sample size of
the TOT group not statistically significant [21]. A limita-
tion of our investigation was the duration of follow up.
However, there are no publications comprising a follow
up of 5 or more years also performing a differentiated
approach on the outcome of obese female. So are the
outcomes of transobturator tape procedure generally
durable in long-term follow-up? A 5-year follow-up
study comparing Burch colposuspension and transob-
turator tape for the surgical treatment of SUI in person
without another concomitant procedure showed, that
the 5-year cure rates were similar (objective cure rate,
73.9% versus 77.5%; subjective cure rate, 76.8% versus
81.7% [22]. Yonguc et al. showed in their publication
that objective cure, subjective cure and patient satisfac-
tion rates of the 126 women at 1 year after transobtura-
tor tape procedure were 89.6, 86.5 and 92% respectively.
During 5-year follow-up, objective cure rate was stable
with 87.3% rate, whereas subjective cure and patient sat-
isfaction rates were decreased to 65.9 and 73%, respect-
ively [23]. The group of Heinonen et al. evaluated 191
patients underwent TOT procedure, and thereby 139
(73%) after a mean follow-up of 6.5 years. The patient
cohort was heterogeneous and consisted of patients withSUI and mixed urinary incontinence (MUI) as well as re-
current SUI. There objective and subjective cure rates
were 89% and 83%, respectively. Subjective cure rate was
84% at 20-month follow-up and was maintained up to
6.5 years. At long-term follow-up, the objective cure rate
was slightly greater than the subjective cure rate. In their
evaluated cohort, mean body mass index BMI was 28
(range, 19–45). Patients with BMI higher 30 had signifi-
cantly higher scores on condition-specific questionnaires
and significantly lower scores on quality of Life ques-
tionnaires, indicating a lower general quality of life and
health than in patients with BMI less or equal 30 [24].
In the subgroup analysis of our sample we could not
confirm this effect for the objective cure rate.
Another limitation of our investigation was the sample
size. We deliberately limited our sample to women with
isolated SUI. On the other hand, our population was
representative of women typically seen in the clinic com-
plaining of isolated SUI. Our results thus help confirm
the effectiveness of the TOT procedure for women in a
general clinical setting.
Conclusions
Our data demonstrate that TOT procedure is safe and
effective. BMI did not influence the outcome of TOT
procedures at a median of 21 months after surgery and
represents no contraindication for continence surgery.
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